-
Racial and ethnic disparities in prostate cancer screening following the 2018 US Preventive Services Task Force recommendation statement J. Med. Screen. (IF 2.9) Pub Date : 2024-04-22 Nathan VanderVeer-Harris, Zachary D Zippi, Dev P Patel, Murugesan Manoharan, Jorge R Caso, Georgeta D Vaidean
ObjectiveIn 2018, the United States Preventive Services Task Force promoted shared decision making between healthcare provider and patient for men aged 55 to 69. This study aimed to analyze rates of prostate-specific antigen (PSA) testing across racial and ethnic groups following this new recommendation.MethodsA secondary analysis was conducted of the 2020–2021 Behavioral Risk Factor Surveillance System
-
Cancer screening programs in Japan: Progress and challenges J. Med. Screen. (IF 2.9) Pub Date : 2024-03-28 Chisato Hamashima, Hirokazu Takahashi
National screening programs for gastric, colorectal, lung, breast, and cervical cancers are offered in Japan. The initial introduction of cancer screening programs was decided based on experts’ opinions. Since 2003, the research groups funded by the National Cancer Center have published screening guidelines for gastric, colorectal, lung, prostate, cervical, and breast cancers. Although such guidelines
-
Examining the impact of COVID-19 disruptions on population-based breast cancer screening in Ireland J. Med. Screen. (IF 2.9) Pub Date : 2024-03-21 Jessica O’Driscoll, Therese Mooney, Paul Kearney, Yvonne Williams, Suzanne Lynch, Alissa Connors, Aideen Larke, Sorcha McNally, Ann O’Doherty, Laura Murphy, Kathleen E. Bennett, Patricia Fitzpatrick, Maeve Mullooly, Fidelma Flanagan
ObjectiveMany population-based breast screening programmes temporarily suspended routine screening following the COVID-19 pandemic onset. This study aimed to describe screening mammography utilisation and the pattern of screen-detected breast cancer diagnoses following COVID-19-related screening disruptions in Ireland.MethodsUsing anonymous aggregate data from women invited for routine screening, three
-
Public cervical cancer screening recommendations from US cancer centers: Assessing adherence to national guidelines J. Med. Screen. (IF 2.9) Pub Date : 2024-03-20 Sophia Salingaros, Yiwey Shieh, Madelon L Finkel, Margaret Polaneczky, Deborah Korenstein, Jennifer L Marti
Though widespread adoption of cervical cancer screening (CCS) in the US has been associated with a reduction in cervical cancer incidence and mortality, screening also carries with it potential risks. Newer national guidelines recommend decreased screening frequency to optimize the benefit/risk balance and to prevent over-screening. Here, we examined the alignment of US cancer center websites’ public
-
Comparing screening based on the NHS Health Check and Polypill Prevention Programmes in the primary prevention of heart attacks and strokes J. Med. Screen. (IF 2.9) Pub Date : 2024-03-15 Nicholas J. Wald, Aroon D. Hingorani, Stephen H. Vale, Jonathan P. Bestwick, Joan Morris
ObjectiveTo compare the NHS Health Check Programme with the Polypill Prevention Programme in the primary prevention of heart attacks and strokes.DesignUse of published data and methodology to produce flow charts of the two programmes to determine screening performance and heart attacks and strokes prevented.SettingThe UK population.InterventionThe NHS Health Check Programme using a QRISK score on people
-
The polypill in the primary prevention of heart attacks and strokes: Overcoming barriers to implementation J. Med. Screen. (IF 2.9) Pub Date : 2024-03-15 Nicholas J Wald, Aroon D Hingorani, Stephen H Vale, Jonathan P Bestwick, Joan Morris
This commentary, linked to our paper in the same issue of the Journal of Medical Screening, discusses the reluctance to consider and adopt the polypill in the primary prevention of heart attacks and strokes, access to the polypill as a public health service, the formulation of the polypill in current use, its prescription as an unlicensed medicine, and what can be done to facilitate the adoption of
-
Association between time to colonoscopy after positive fecal testing and colorectal cancer outcomes in Alberta, Canada J. Med. Screen. (IF 2.9) Pub Date : 2024-03-15 Darren R Brenner, Chantelle Carbonell, Linan Xu, Nicole Nemecek, Huiming Yang
ObjectiveTo quantify the associations between time to colonoscopy after a positive fecal immunochemical test (FIT+) and colorectal cancer (CRC)-related outcomes in the context of a provincial, population-based CRC screening program.SettingPopulation-based, retrospective cohort study in Alberta, Canada, including Albertans aged 50–74 with at least one FIT+ in 2014–2017.MethodsStudy outcomes were CRC
-
Age-specific differences in tumour characteristics between screen-detected and non-screen-detected breast cancers in women aged 40–74 at diagnosis in Sweden from 2008 to 2017 J. Med. Screen. (IF 2.9) Pub Date : 2024-03-08 Håkan Jonsson, Anne Andersson, Zheng Mao, Lennarth Nyström
ObjectiveTo analyze differences between screen-detected and non-screen-detected invasive breast cancers by tumour characteristics and age at diagnosis in the nationwide population-based mammography screening program in Sweden.MethodsData were retrieved from the National Quality Register for Breast Cancer for 2008–2017. Logistic regression analysis was used to estimate the likelihood for a tumour to
-
Effects of health education on screening rate of first-degree relatives of cancer patients: A systematic review and meta-analysis J. Med. Screen. (IF 2.9) Pub Date : 2024-02-27 Jiaxun Kang, Shanshan Wang, Jingna Yi, Qiushi Zhang
ObjectiveTo synthesize the effects of educational intervention on the screening rate of first-degree relatives of cancer patients.MethodsA total of eight Chinese and English databases were searched (PubMed, Embase, Cochrane Library, CINAHL, Web of Science, Scopus, Medline and China Biology Medicine disc) from the time of library establishment to June 2023, for randomized controlled trials investigating
-
How follow-up rates in cervical cancer screening depend on organizational factors: A comparison of two population-based organized screening programmes J. Med. Screen. (IF 2.9) Pub Date : 2024-02-21 Susanne Fogh Jørgensen, Eliane Kellen, Annemie Haelens, Koen Van Herck, Sisse Helle Njor
ObjectivesThis study compares the follow-up rates of non-normal cervical screening samples between Denmark and Flanders (Belgium) to illuminate whether organizational differences between the health systems might affect the follow-up rates, e.g. sending of reminders in Denmark since 2012 compared to Flanders with no such system in place.MethodsThe study population included 48,082 Danish women and 22
-
-
Reducing inequalities by supporting individuals to make informed decisions about accepting their breast screening invitations J. Med. Screen. (IF 2.9) Pub Date : 2024-02-13 Sarah L Nicholson, Heidi Douglas, Stephen Halcrow, Patsy Whelehan
ObjectivesIndividuals from deprived areas are less likely to attend breast screening. Inequalities in the coverage of breast screening are associated with poorer cancer outcomes. Individuals who have a positive first experience are more likely to attend subsequent mammograms. This work evaluates the provision of an additional telephone call to individuals who have never attended breast screening, to
-
Clinical performance and utility: A microsimulation model to inform the design of screening trials for a multi-cancer early detection test J. Med. Screen. (IF 2.9) Pub Date : 2024-02-02 James Y Dai, Jing Zhang, Jerome V Braun, Noah Simon, Earl Hubbell, Nan Zhang
ObjectivesDesigning cancer screening trials for multi-cancer early detection (MCED) tests presents a significant methodology challenge, as natural histories of cell-free DNA-shedding cancers are not yet known. A microsimulation model was developed to project the performance and utility of an MCED test in cancer screening trials.MethodsIndividual natural history of preclinical progression through cancer
-
The prognostic potential of mammographic growth rate of invasive breast cancer in the Nijmegen breast cancer screening cohort J. Med. Screen. (IF 2.9) Pub Date : 2024-01-31 Jim Peters, Jos A.A.M. van Dijck, Sjoerd G. Elias, Johannes D.M. Otten, Mireille J.M. Broeders
ObjectivesInsight into the aggressiveness of potential breast cancers found in screening may optimize recall decisions. Specific growth rate (SGR), measured on mammograms, may provide valuable prognostic information. This study addresses the association of SGR with prognostic factors and overall survival in patients with invasive carcinoma of no special type (NST) from a screened population.MethodsIn
-
Deaths averted: An unbiased alternative to rate ratios for measuring the performance of cancer screening programs. J. Med. Screen. (IF 2.9) Pub Date : 2023-11-21 Wilber Deck,James A Hanley
INTRODUCTION Screening trials and meta-analyses emphasize the ratio of cancer death rates in screening and control arms. However, this measure is diluted by the inclusion of deaths from cancers that only became detectable after the end of active screening. METHODS We review traditional analysis of cancer screening trials and show that ratio estimates are inevitably biased to the null, because follow-up
-
Primary care outreach and decision counseling for lung cancer screening. J. Med. Screen. (IF 2.9) Pub Date : 2023-11-21 Heather Bittner Fagan,Claudine Jurkovitz,Zugui Zhang,L Anna Thompson,Freda Patterson,Martha A Zazzarino,Ronald E Myers
INTRODUCTION Lung cancer screening rates are very low despite a level B recommendation from the United States Preventive Services Task Force since 2013 and clear evidence that lung cancer screening reduces mortality. The Center for Medicare and Medicaid Services requires shared decision-making (SDM) for lung cancer screening reimbursement. The objective of this study was to determine the effect of
-
Racial/ethnic and socioeconomic disparities in colorectal cancer screening in a large organization with universal insurance before and during the coronavirus disease 2019 pandemic. J. Med. Screen. (IF 2.9) Pub Date : 2023-11-14 Zohar Levi,Naim Abu-Frecha,Doron Comanesther,Tania Backenstein,Arnon D Cohen,Sapir Eizenstein,Anath Flugelman,Orly Weinstein
OBJECTIVES Israel is regarded as a country with a developed economy and a moderate income inequality index. In this population-based study, we aimed to measure the inequalities in colorectal cancer screening within Clalit Health, an organization with universal insurance, before and during the coronavirus disease 2019 pandemic. SETTING Retrospective analysis within Clalit Health Services, Israel. METHODS
-
Awareness and knowledge about HPV and primary HPV screening among women in Great Britain: An online population-based survey. J. Med. Screen. (IF 2.9) Pub Date : 2023-10-24 Jo Waller,Frances Waite,Laura Marlow
OBJECTIVES Human papillomavirus (HPV) primary testing for cervical screening is being implemented around the world. We explored HPV awareness, and knowledge about primary screening in Great Britain (England, Scotland and Wales), where it has been in place for several years, ahead of extended screening intervals being implemented in England. SETTING/METHODS Women aged 18-70 (n = 1995) were recruited
-
Overcoming barriers to lung cancer screening using a systemwide approach with additional focus on the non-screened. J. Med. Screen. (IF 2.9) Pub Date : 2023-10-19 Michael R Gieske,Jessica Kerns,Gary M Schmitt,Goetz Kloecker,Irfan A Budhani,Joseph Nolan,Valerie A Williams,Deema Alkapalan,Katelyn Ferguson,Ryan Yadav,Royce F Calhoun
BACKGROUND The lung cancer screening program at St Elizabeth Healthcare (Kentucky, USA) began in 2013. Over 33,000 low-dose computed tomography lung cancer screens have been performed. From 2015 through 2021, 2595 lung cancers were diagnosed systemwide. A Screening Program with Impactful Results from Early Detection, reviews that experience; 342 (13.2%) were diagnosed by screening and 2253 (86.8%)
-
The impact on clinical outcomes and healthcare resources from discontinuing colonoscopy surveillance subsequent to low-risk adenoma removal: A simulation study using the OncoSim-Colorectal model. J. Med. Screen. (IF 2.9) Pub Date : 2023-09-20 Kieran Jd Steer,Zhuolu Sun,Daniel C Sadowski,Jean H E Yong,Andrew Coldman,Nicole Nemecek,Huiming Yang
OBJECTIVE To estimate the impact on clinical outcomes and healthcare resource use from recommending that patients with 1-2 low-risk adenomas (LRAs) return to routine fecal immunochemical test (FIT) screening instead of surveillance colonoscopy, from a Canadian provincial healthcare system perspective. METHODS The OncoSim-Colorectal microsimulation model simulated average-risk individuals eligible for
-
Early performance measures following regular versus irregular screening attendance in the population-based screening program for breast cancer in Norway. J. Med. Screen. (IF 2.9) Pub Date : 2023-09-11 Jonas E Thy,Marthe Larsen,Einar Vigeland,Henrik Koch,Tone Hovda,Solveig Hofvind
OBJECTIVE Irregular attendance in breast cancer screening has been associated with higher breast cancer mortality compared to regular attendance. Early performance measures of a screening program following regular versus irregular screening attendance have been less studied. We aimed to investigate early performance measures following regular versus irregular screening attendance. METHODS We used information
-
Applying the healthcare failure mode and effects analysis approach to improve the quality of an organised colorectal cancer screening programme. J. Med. Screen. (IF 2.9) Pub Date : 2023-09-07 Angela Chiereghin,Lorena Squillace,Lorenzo Pizzi,Carmen Bazzani,Lorenzo Roti,Francesca Mezzetti
OBJECTIVE The first level of a colorectal cancer (CRC) screening process was systematically analysed using the Healthcare Failure Mode and Effects Analysis (HFMEA) approach by a multidisciplinary team aiming to improve the programme quality. SETTING The study was conducted at the Local Health Authority of Bologna, Northern Italy. METHODS Seven brainstorming sessions were conducted and all the activities
-
The recalibration and redevelopment of a model to calculate patients' probability of completing a colonoscopy following an abnormal fecal test. J. Med. Screen. (IF 2.9) Pub Date : 2023-09-04 Amanda F Petrik,Eric S Johnson,Matthew Slaughter,Michael C Leo,Jamie Thompson,Rajasekhara R Mummadi,Ricardo Jimenez,Syed Akmal Hussain,Gloria Coronado
OBJECTIVES Fecal immunochemical testing (FIT) is an effective screening tool for colorectal cancer. If an FIT is abnormal, a follow-up colonoscopy is necessary to remove polyps or find cancers. We sought to develop a usable risk prediction model to identify patients unlikely to complete a colonoscopy following an abnormal FIT test. METHODS We recalibrated and then redeveloped a prediction model in
-
Including the method of detection for breast cancer in the Surveillance, Epidemiology, and End Results database is long overdue. J. Med. Screen. (IF 2.9) Pub Date : 2023-08-25 Daniel B Kopans,Richard E Sharpe,Peter R Eby
Debates about breast cancer screening have continued in part because the Surveillance, Epidemiology, and End Results database, which began in 1974, has never included the method of detection so that it has been impossible to determine the role that early detection has played in the major decline in deaths from breast cancer that we have seen in the US since 1990. Method of detection should be added
-
Combining genetic and non-genetic risk factors to predict disease, and reporting the screening performance of risk models. J. Med. Screen. (IF 2.9) Pub Date : 2023-08-24 Robert Old
-
Optimising recruitment to a lung cancer screening trial: A comparison of general practitioner and community-based recruitment. J. Med. Screen. (IF 2.9) Pub Date : 2023-08-01 Hannah Scobie,Kathryn A Robb,Sara Macdonald,Stephen Harrow,Frank Sullivan,
OBJECTIVES Pre-trial focus groups of the Early detection of Cancer of the Lung Scotland (ECLS) trial indicated that those at high risk of lung cancer are more likely to engage with community-based recruitment methods. The current study aimed to understand if general practitioner (GP) and community-based recruitment might attract different groups of people, and to quantitatively explore the demographic
-
Interval cancers in a national colorectal screening programme based on faecal immunochemical testing: Implications for faecal haemoglobin concentration threshold and sex inequality. J. Med. Screen. (IF 2.9) Pub Date : 2023-07-19 Gavin Rc Clark,Thomas Godfrey,Calum Purdie,Judith Strachan,Francis A Carey,Callum G Fraser,Robert Jc Steele
OBJECTIVE To compare interval cancer proportions (ICP) in the faecal immunochemical test (FIT)-based Scottish Bowel Screening Programme (SBoSP) with the former guaiac faecal occult blood test (gFOBT)-based SBoSP and investigate associations between interval cancer (IC) and faecal haemoglobin concentration (f-Hb) threshold, sex, age, deprivation, site, and stage. METHODS The ICP data from first year
-
Participation in the national cervical screening programme among women from New South Wales, Australia, by place of birth and time since immigration: A data linkage analysis using the 45 and up study. J. Med. Screen. (IF 2.9) Pub Date : 2023-07-19 Susan Yuill,Sam Egger,Megan A Smith,Louiza Velentzis,Marion Saville,Erich V Kliewer,Deborah Bateson,Karen Canfell
OBJECTIVE Equitable elimination of cervical cancer in Australia within the next decade will require high National Cervical Screening Program (NCSP) participation by all subgroups of women. The aim of this study was to examine the participation of immigrants compared to Australian-born women. METHODS Participation in the NCSP (≥1cytology test) over a 3-year (2010-2012) and 5-year (2008-2012) period
-
Colorectal cancer screening with faecal immunochemical test: Patterns of participation. J. Med. Screen. (IF 2.9) Pub Date : 2023-07-18 Hanna Heyman,Johannes Blom,Deborah Saraste
OBJECTIVE To evaluate participation and participation patterns in a population-based screening programme for colorectal cancer (CRC) using the faecal immunochemical test (FIT). METHODS All individuals invited to three consecutive screening rounds in the population-based CRC screening between October 2015 and December 2020 in the Stockholm-Gotland Region, Sweden were included. Patterns of participation
-
Interval cancer after two rounds of a Swedish population-based screening program using gender-specific cut-off levels in fecal immunochemical test. J. Med. Screen. (IF 2.9) Pub Date : 2023-07-16 Hanna Ribbing Wilén,Johannes Blom
OBJECTIVE To evaluate interval cancer (IC) after two screening rounds of the Swedish population-based screening program of Stockholm-Gotland applying gender-specific cut-off levels in the fecal immunochemical test (FIT). METHODS All 60- to 69-year-olds invited to screening 2015-2019 were included. The cut-off level for a positive test was 40 µg/g in women and 80 µg/g in men. Screening-detected colorectal
-
Carrier rate of thalassemia among 25,910 high school students in Shaoguan area, China. J. Med. Screen. (IF 2.9) Pub Date : 2023-07-12 Yajun Chen,Rui Zhong,Xueqin Guo,Shiping Chen,Yan Wang,Jiufeng Li,Lichan Huang,Yi Li,Xiaoling Wang,Liting Wu,Mubao Huang,Xiaoyan Huang,Junbin Fang,Zhongjie Chu,Jun Sun,Zhiyu Peng,Yan Sun
OBJECTIVES As one of the most common hereditary diseases, thalassemia affects a large number of people in China. The aim of this study was to investigate the feasibility of a method based on next-generation sequencing (NGS) for screening of thalassemia carriers among high school students in the Shaoguan area. MATERIALS AND METHODS The NGS-based method was performed using 25,910 high school students
-
Long-term cause of death patterns and mode of breast cancer detection in The Netherlands, 2004-2019. J. Med. Screen. (IF 2.9) Pub Date : 2023-06-26 Johannes D M Otten,André L M Verbeek,Mireille J M Broeders
OBJECTIVE Early detection through mammographic screening and various treatment modalities of cancer may have changed life expectancy and cause-specific mortality of breast cancer patients. We aimed to determine the long-term cause of death patterns in screening-detected patients and clinically diagnosed patients in the Netherlands compared with the general population. METHODS Using data from the Netherlands
-
Risk of cancer versus risk of cancer diagnosis? Accounting for diagnostic bias in predictions of breast cancer risk by race and ethnicity. J. Med. Screen. (IF 2.9) Pub Date : 2023-06-12 Charlotte C Gard,Jane Lange,Diana L Miglioretti,Ellen S O'Meara,Christoph I Lee,Ruth Etzioni
OBJECTIVES Cancer risk prediction may be subject to detection bias if utilization of screening is related to cancer risk factors. We examine detection bias when predicting breast cancer risk by race/ethnicity. METHODS We used screening and diagnosis histories from the Breast Cancer Surveillance Consortium to estimate risk of breast cancer onset and calculated relative risk of onset and diagnosis for
-
Is it feasible to enhance quality assurance of cervical cancer screening in Latin America? A regional expert consensus. J. Med. Screen. (IF 2.9) Pub Date : 2023-06-08 Valentina Rangel,Ginna Paola Fernández-Deaza,Juan Sebastián Castillo,Raúl Murillo
OBJECTIVES Cervical cancer elimination requires high-performance screening tests and high treatment rates, and thus high screening program performance is essential; however, Latin America lacks organized screening and quality assurance (QA) guidelines. We aimed to develop a core set of QA indicators suitable to the region. METHODS We reviewed QA guidelines from countries/regions with highly organized
-
Differential impact of test performance characteristics on burden-to-benefit tradeoffs for blood-based colorectal cancer screening: A microsimulation analysis. J. Med. Screen. (IF 2.9) Pub Date : 2023-06-02 Andrew Piscitello,Lauren N Carroll,Signe Fransen,Ben Wilson,Tarun Chandra,Reinier Meester,Girish Putcha
OBJECTIVES To inform the development and evaluation of new blood-based colorectal cancer (CRC) screening tests satisfying minimum United States (US) coverage criteria, we estimated the impact of the different test performance characteristics on long-term testing benefits and burdens. METHODS A novel CRC-Microsimulation of Adenoma Progression and Screening (CRC-MAPS) model was developed, validated,
-
Prevalence of colorectal cancer and breast cancer screening according to history of diabetes in 2010-2019. J. Med. Screen. (IF 2.9) Pub Date : 2023-05-31 Zechen Liu,Mingyang Song
As cancer is overtaking cardiovascular disease as the leading cause of death among diabetics, improved cancer prevention efforts are needed for individuals with diabetes. In this research letter, we used data from the US National Health Interview Survey to examine the use of screening for two major diabetes-related cancers, colorectal cancer, and breast cancer, in individuals with and without diabetes
-
Improved use of faecal immunochemical tests for haemoglobin in the Scottish bowel screening programme. J. Med. Screen. (IF 2.9) Pub Date : 2023-05-25 Jayne Digby,Callum G Fraser,Gavin Clark,Craig Mowat,Judith A Strachan,Robert Jc Steele
OBJECTIVES This study aimed to develop a risk-scoring model in the Scottish Bowel Screening Programme incorporating faecal haemoglobin concentration with other risk factors for colorectal cancer. METHODS Data were collected for all individuals invited to participate in the Scottish Bowel Screening Programme between November 2017 and March 2018 including faecal haemoglobin concentration, age, sex, National
-
The 5-year risk of recurrence of grade 2/3 cervical intraepithelial neoplasia after treatment in a population screening programme by human papillomavirus status: A cohort study in central Italy. J. Med. Screen. (IF 2.9) Pub Date : 2023-05-25 Carmen Beatriz Visioli,Anna Iossa,Giuseppe Gorini,Paola Mantellini,Lisa Lelli,Noemi Auzzi,Carmelina Di Pierro,Francesca Maria Carozzi,Marco Zappa
OBJECTIVES (a) To estimate the risk of recurrent cervical intraepithelial neoplasia, grade 2/3 or worse (CIN2+/CIN3+), lesions within 5 years of follow-up in human papillomavirus-negative/human papillomavirus-positive cohorts; (b) to assess whether certain risk factors can predict the recurrence of CIN2+/CIN3+ lesions; and (c) to provide recommendations for follow-up after treatment of cervical intraepithelial
-
Cell-free DNA-based prenatal screening via rolling circle amplification: Identifying and resolving analytic issues. J. Med. Screen. (IF 2.9) Pub Date : 2023-05-17 Glenn E Palomaki,Geralyn M Lambert-Messerlian,Donna Fullerton,Madhuri Hegde,Stéphanie Conotte,Matthew L Saidel,Jacques C Jani
OBJECTIVE A rolling circle amplification (RCA) based commercial methodology using cell-free (cf)DNA to screen for common trisomies became available in 2018. Relevant publications documented high detection but with a higher than expected 1% false positive rate. Preliminary evidence suggested assay variability was an issue. A multi-center collaboration was created to explore this further and examine
-
Trends in colorectal cancer screening in the United States, 2012 to 2020 J. Med. Screen. (IF 2.9) Pub Date : 2023-05-08 Yue He, Tong Xu, Jiaxin Fang, Li Tong, Wenhui Gao, Yuan Zhang, Yanfang Wang, Yan Xu, Shunyao Shi, Siyu Liu, Lina Jin
ObjectivesDespite recommendations to increase the uptake of colorectal cancer (CRC) screening, trends in CRC screening vary with sociodemographic status. We aimed to evaluate trends in CRC screenin...
-
Outcome of premarital genetic counseling for couples at risk of hemoglobinopathies in Kingdom of Bahrain J. Med. Screen. (IF 2.9) Pub Date : 2023-04-17 Samya Bahram, Aalaa Haji, Hawra Abdulwahab, Hanan Mohsen, Tahera Alnashaba, Zainab Al-Aradi, Mohamed Mandeel
ObjectivesHemoglobinopathies are the commonest inherited blood disorders and form a serious burden worldwide, affecting communities, patient quality of life and healthcare resources. The Kingdom of...
-
The Consensus Project: Participation in cervical cancer screening by the first cohorts of girls offered HPV vaccination at age 15–16 years in Italy J. Med. Screen. (IF 2.9) Pub Date : 2023-03-30 Carmen B Visioli, Paolo Giorgi Rossi, Paola Armaroli, Anna Iossa, Raffaella Rizzolo, Luigina A Bonelli, Ezio Venturino, Francesca M Carozzi, Simonetta Bisanzi, Laura De Marco, Livia Giordano, Elisa Camussi, Annarosa Del Mistro, Marco Zappa
ObjectiveTo evaluate the association between human papillomavirus vaccination status and participation in cervical cancer screening (at age 25) by the first cohorts of girls who were offered vaccin...
-
Overview of organisational methods of primary cervical lesion screening programmes that use human papillomavirus testing J. Med. Screen. (IF 2.9) Pub Date : 2023-03-28 Agathe Marchadier, Laura Bezannier, Stéphanie Barré-Pierrel, Antoine Manceau, Audrey A Abadie, Bruno Detournay
Many factors need to be considered when planning and managing a screening programme for the early detection of cervical cancer (CC). A non-systematic international review of the organisation of CC ...
-
Validation of a monoclonal unconjugated estriol antibody for use in prenatal maternal serum screening J. Med. Screen. (IF 2.9) Pub Date : 2023-03-14 Geralyn M Lambert-Messerlian, Jonathan P Bestwick, Nicholas J Wald
ObjectivesUnconjugated estriol (uE3) is used as a marker for fetal aneuploidy in maternal serum screening tests. The goal of this study was to examine the validity of a new immunoassay for uE3 that...
-
Timely adherence to follow-up after high-risk lung cancer screenings J. Med. Screen. (IF 2.9) Pub Date : 2023-03-14 Dustin Kee, Keith M. Sigel, Juan P. Wisnivesky, Minal S. Kale
ObjectiveTo achieve the lung cancer screening (LCS) mortality benefit in clinical trials, timely, real-world follow-up of abnormal test results is necessary. Presently, annual LCS rates are lower t...
-
Overcoming barriers: Modelling the effect of potential future changes of organized breast cancer screening in Italy J. Med. Screen. (IF 2.9) Pub Date : 2023-02-10 Nadine Zielonke, Carlo Senore, Antonio Ponti, Marcell Csanadi, Harry J de Koning, Eveline A M Heijnsdijk, Nicolien T van Ravesteyn
ObjectivesOrganized breast cancer screening may not achieve its full potential due to organizational and cultural barriers. In Italy, two identified barriers were low attendance in Southern Italy a...
-
Estimating stage-specific sensitivity for cancer screening tests J. Med. Screen. (IF 2.9) Pub Date : 2023-02-03 Paul Pinsky, Jane Lange, Ruth Etzioni
ObjectivesWhen evaluating potential new cancer screening modalities, estimating sensitivity, especially for early-stage cases, is critical. There are methods to approximate stage-specific sensitivi...
-
Test accuracy of artificial intelligence-based grading of fundus images in diabetic retinopathy screening: A systematic review J. Med. Screen. (IF 2.9) Pub Date : 2023-01-09 Zhivko Zhelev, Jaime Peters, Morwenna Rogers, Michael Allen, Goda Kijauskaite, Farah Seedat, Elizabeth Wilkinson, Christopher Hyde
ObjectivesTo systematically review the accuracy of artificial intelligence (AI)-based systems for grading of fundus images in diabetic retinopathy (DR) screening.MethodsWe searched MEDLINE, EMBASE,...
-
“It's cancer screening after all”. Barriers to cervical and colorectal cancer screening and attitudes to promotion of self-sampling kits upon attendance for breast cancer screening J. Med. Screen. (IF 2.9) Pub Date : 2022-12-21 Pia Kirkegaard, Mette Bach Larsen, Berit Andersen
ObjectivesTo explore barriers to cervical and colorectal cancer screening and attitudes to promotion of self-sampling kits upon attendance for breast cancer screening.MethodsInterview study with wo...
-
Public health perspective on prostate-specific antigen screening: Implications of overdiagnosis and differences in health insurance systems across countries. J. Med. Screen. (IF 2.9) Pub Date : 2022-11-22 Takeshi Takahashi
-
Couple screening for recessively inherited disorders J. Med. Screen. (IF 2.9) Pub Date : 2022-11-17 Silvina Sisterna, Antoni Borrell
Couple screening aims to identify couples with an increased risk of having a child affected with an autosomal recessive or X-linked disorder, in order to facilitate informed reproductive decision m...
-
Age at breast cancer screening in women with intellectual disability. J. Med. Screen. (IF 2.9) Pub Date : 2022-10-26 Daniel Satgé,Motoi Nishi
-
Did the use of open invitations in place of timed appointment invitations reduce the uptake of breast screening in the London region during the COVID-19 recovery? J. Med. Screen. (IF 2.9) Pub Date : 2022-10-11 Sue M Hudson, Kathie Binysh, Stephen W Duffy
ObjectiveThe Covid-19 pandemic created a backlog of women awaiting an invitation for breast screening in the UK. To recover in a timely fashion, the National Health Service programme opted to issue...
-
Availability of data for cost-effectiveness comparison of child vision and hearing screening programmes J. Med. Screen. (IF 2.9) Pub Date : 2022-10-07 Jan Kik, Eveline A.M. Heijnsdijk, Allison R. Mackey, Gwen Carr, Anna M Horwood, Maria Fronius, Jill Carlton, Helen J Griffiths, Inger M Uhlén, Huibert Jan Simonsz, Country-Committees Joint-Partnership of the EUSCREEN Study Consortium
ObjectiveFor cost-effectiveness comparison of child vision and hearing screening programmes, methods and data should be available. We assessed the current state of data collection and its availabil...
-
Impact of the COVID-19 pandemic on colorectal cancer screening in New York City J. Med. Screen. (IF 2.9) Pub Date : 2022-09-26 Briton Lee, Sigrid Young, Renee Williams, Peter S Liang
BackgroundThe COVID-19 pandemic significantly impacted the delivery of cancer screening. The resulting decrease in outpatient visits and cancellations of non-urgent procedures have negatively affec...
-
Interval cancer audit and disclosure in breast screening programmes: An international survey J. Med. Screen. (IF 2.9) Pub Date : 2022-09-07 Patricia Fitzpatrick, Helen Byrne, Fidelma Flanagan, Ann O’Doherty, Alissa Connors, Aideen Larke, Risteard O’Laoide, Yvonne Williams, Therese Mooney
Objective and SettingAccurate monitoring of interval cancers is important both for quality improvement and education and is a key parameter of breast screening quality assurance. Issues in relation...
-
The impact of the COVID-19 pandemic on breast cancer screening and diagnosis in a Brazilian metropolitan area J. Med. Screen. (IF 2.9) Pub Date : 2022-09-07 Erika Marina Solla Negrao, Cesar Cabello, Livia Conz, Edmundo Carvalho Mauad, Luiz Carlos Zeferino, Diama Bhadra Vale
ObjectivesTo evaluate the performance of breast cancer screening and early diagnosis during the pandemic, compared to the pre-pandemic period.Setting: The public referral centre for screening in Ca...
-
Factors associated with women's supplemental screening intentions following dense breast notification in an online randomised experimental study J. Med. Screen. (IF 2.9) Pub Date : 2022-09-07 Brooke Nickel, Hankiz Dolan, Nehmat Houssami, Erin Cvejic, Meagan Brennan, Jolyn Hersch, Melanie Dorrington, Angela Verde, Lisa Vaccaro, Kirsten McCaffery
Controversy surrounding recommendations for supplemental screening (ultrasound and magnetic resonance screening) in women with dense breasts exists, as the long-term benefits from these additional ...
-
Screening asymptomatic men for prostate cancer: A comparison of international guidelines on prostate-specific antigen testing J. Med. Screen. (IF 2.9) Pub Date : 2022-09-04 Sherena D Jackson, May R de la Rue, Thomas PL Greenslade, Anna M John, Shahida Wahid, Richard M Martin, Naomi J Williams, Emma L Turner
Objective To summarise and compare the key recommendations on prostate-specific antigen (PSA)-based screening for prostate cancer, and so highlight where more evidence is required to facilitate con...
-
Acceptability of alternative technologies compared with faecal immunochemical test and/or colonoscopy in colorectal cancer screening: A systematic review J. Med. Screen. (IF 2.9) Pub Date : 2022-08-29 Omar Ali, Sunnia Gupta, Kate Brain, Kate J Lifford, Shantini Paranjothy, Sunil Dolwani
ObjectiveColorectal cancer (CRC) is the third most common cancer and the second largest cause of cancer-related death worldwide. Current CRC screening in various countries involves stool-based faec...